ETB is a benzoxaboroles analogue and leucyl-tRNA synthetase (LeuRS) inhibitor and it has a novel mode of action against Gram-negative bacterial infection such as urinary tract infections [41,42]. This evidence concerns the gene LARS1 and gram-negative bacterial infections.